Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-Analysis
We conducted an updated meta-analysis to evaluate the 30-day mortality of hip fractures during the COVID-19 pandemic and assess mortality rates by country. We systematically searched Medline, EMBASE, and the Cochrane Library up to November 2022 for studies on the 30-day mortality of hip fractures du...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/4/669 |
_version_ | 1797604762018906112 |
---|---|
author | Sojune Hwang Chiwon Ahn Moonho Won |
author_facet | Sojune Hwang Chiwon Ahn Moonho Won |
author_sort | Sojune Hwang |
collection | DOAJ |
description | We conducted an updated meta-analysis to evaluate the 30-day mortality of hip fractures during the COVID-19 pandemic and assess mortality rates by country. We systematically searched Medline, EMBASE, and the Cochrane Library up to November 2022 for studies on the 30-day mortality of hip fractures during the pandemic. Two reviewers used the Newcastle–Ottawa tool to independently assess the methodological quality of the included studies. We conducted a meta-analysis and systematic review including 40 eligible studies with 17,753 patients with hip fractures, including 2280 patients with COVID-19 (12.8%). The overall 30-day mortality rate for hip fractures during the pandemic was 12.6% from published studies. The 30-day mortality of patients with hip fractures who had COVID-19 was significantly higher than those without COVID-19 (OR, 7.10; 95% CI, 5.51–9.15; I<sup>2</sup> = 57%). The hip fracture mortality rate increased during the pandemic and varied by country, with the highest rates found in Europe, particularly the United Kingdom (UK) and Spain. COVID-19 may have contributed to the increased 30-day mortality rate in hip fracture patients. The mortality rate of hip fracture in patients without COVID-19 did not change during the pandemic. |
first_indexed | 2024-03-11T04:51:20Z |
format | Article |
id | doaj.art-bc97e3ceb8e045788e3df4b4d69c43cb |
institution | Directory Open Access Journal |
issn | 2075-4426 |
language | English |
last_indexed | 2024-03-11T04:51:20Z |
publishDate | 2023-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Personalized Medicine |
spelling | doaj.art-bc97e3ceb8e045788e3df4b4d69c43cb2023-11-17T20:00:28ZengMDPI AGJournal of Personalized Medicine2075-44262023-04-0113466910.3390/jpm13040669Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-AnalysisSojune Hwang0Chiwon Ahn1Moonho Won2Department of Emergency Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Republic of KoreaDepartment of Emergency Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Republic of KoreaDepartment of Emergency Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Republic of KoreaWe conducted an updated meta-analysis to evaluate the 30-day mortality of hip fractures during the COVID-19 pandemic and assess mortality rates by country. We systematically searched Medline, EMBASE, and the Cochrane Library up to November 2022 for studies on the 30-day mortality of hip fractures during the pandemic. Two reviewers used the Newcastle–Ottawa tool to independently assess the methodological quality of the included studies. We conducted a meta-analysis and systematic review including 40 eligible studies with 17,753 patients with hip fractures, including 2280 patients with COVID-19 (12.8%). The overall 30-day mortality rate for hip fractures during the pandemic was 12.6% from published studies. The 30-day mortality of patients with hip fractures who had COVID-19 was significantly higher than those without COVID-19 (OR, 7.10; 95% CI, 5.51–9.15; I<sup>2</sup> = 57%). The hip fracture mortality rate increased during the pandemic and varied by country, with the highest rates found in Europe, particularly the United Kingdom (UK) and Spain. COVID-19 may have contributed to the increased 30-day mortality rate in hip fracture patients. The mortality rate of hip fracture in patients without COVID-19 did not change during the pandemic.https://www.mdpi.com/2075-4426/13/4/669hip fractureCOVID-19pandemicmortality |
spellingShingle | Sojune Hwang Chiwon Ahn Moonho Won Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-Analysis Journal of Personalized Medicine hip fracture COVID-19 pandemic mortality |
title | Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-Analysis |
title_full | Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-Analysis |
title_fullStr | Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-Analysis |
title_full_unstemmed | Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-Analysis |
title_short | Comparing the 30-Day Mortality for Hip Fractures in Patients with and without COVID-19: An Updated Meta-Analysis |
title_sort | comparing the 30 day mortality for hip fractures in patients with and without covid 19 an updated meta analysis |
topic | hip fracture COVID-19 pandemic mortality |
url | https://www.mdpi.com/2075-4426/13/4/669 |
work_keys_str_mv | AT sojunehwang comparingthe30daymortalityforhipfracturesinpatientswithandwithoutcovid19anupdatedmetaanalysis AT chiwonahn comparingthe30daymortalityforhipfracturesinpatientswithandwithoutcovid19anupdatedmetaanalysis AT moonhowon comparingthe30daymortalityforhipfracturesinpatientswithandwithoutcovid19anupdatedmetaanalysis |